Lista de obras - Javier Sáez - Dominio Público Uruguay

Acetylcholinesterase activation in organotypic rat hippocampal slice cultures deprived of oxygen and glucose.

artículo científico publicado en 2003

Acetylcholinesterase level and molecular isoforms are altered in brain of Reelin Orleans mutant mice ⬇️

artículo científico publicado el 1 de noviembre de 2003

Acetylcholinesterase modulates presenilin-1 levels and γ-secretase activity.

artículo científico publicado en 2014

Acetylcholinesterase protein level is preserved in the Alzheimer's brain

artículo científico publicado en 2013

Alterations in the Balance of Amyloid-β Protein Precursor Species in the Cerebrospinal Fluid of Alzheimer's Disease Patients

artículo científico publicado en 2017

Altered expression of brain acetylcholinesterase in FTDP-17 human tau transgenic mice.

artículo científico publicado en 2011

Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque deposition.

artículo científico publicado en 2002

Altered glycosylation of acetylcholinesterase in Creutzfeldt-Jakob disease.

artículo científico publicado en 2005

Altered glycosylation of acetylcholinesterase in the Creutzfeldt-Jakob cerebrospinal fluid

scientific article published on 01 January 2006

Altered glycosylation of cerebrospinal fluid butyrylcholinesterase in Alzheimer's disease.

artículo científico publicado en 2001

Altered levels of acetylcholinesterase in Alzheimer plasma

artículo científico publicado en 2010

Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease.

artículo científico publicado en 2003

Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer's disease

artículo científico publicado en 2020

ApoER2 processing by presenilin-1 modulates reelin expression

artículo científico publicado en 2013

Association between acetylcholinesterase and beta-amyloid peptide in Alzheimer's cerebrospinal fluid.

scientific article published on 07 May 2008

Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease

artículo científico publicado en 2009

Biochemical properties of acetyl- and butyrylcholinesterase in human meningioma.

artículo científico publicado en 1996

Brain cholinergic impairment in liver failure.

artículo científico publicado en 2008

Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis.

artículo científico publicado en 2006

C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease

artículo científico publicado en 2017

CSF Presenilin-1 complexes are increased in Alzheimer's disease

scientific article published on 06 August 2013

Caspase-3 activation by beta-amyloid and prion protein peptides is independent from their neurotoxic effect

scientific article published on 01 November 2000

Cerebrospinal fluid acetylcholinesterase changes after treatment with donepezil in patients with Alzheimer's disease

artículo científico publicado en 2007

Changes in acetylcholinesterase expression are associated with altered presenilin-1 levels.

artículo científico publicado en 2011

Changes in molecular isoform distribution of acetylcholinesterase in rat cortex and cerebrospinal fluid after intracerebroventricular administration of amyloid beta-peptide.

artículo científico publicado en 2002

Characterization of Cerebrospinal Fluid BACE1 Species

scientific article published on 09 July 2019

Characterization of molecular forms of acetyl- and butyrylcholinesterase in human acoustic neurinomas

artículo científico publicado en 1999

Decreased circulating ErbB4 ectodomain fragments as a read-out of impaired signaling function in amyotrophic lateral sclerosis

artículo científico publicado en 2018

Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease.

artículo científico publicado en 2003

Glycosylation of acetylcholinesterase as diagnostic marker for Alzheimer's disease.

artículo científico publicado en 1997

Identification of a 31-bp deletion in the RELN gene causing lissencephaly with cerebellar hypoplasia in sheep.

artículo científico publicado en 2013

Inhibition of neurite outgrowth from chick sympathetic neurons by cholinesterase inhibitors is not mediated by binding to cholinesterases

scientific article published on 01 May 1999

Inhibition of γ-Secretase Leads to an Increase in Presenilin-1.

artículo científico

Intraperitoneal administration of 340 kDa human plasma butyrylcholinesterase increases the level of the enzyme in the cerebrospinal fluid of rats.

artículo científico publicado en 2005

Levels of ADAM10 are reduced in Alzheimer's disease CSF

scientific article published on 25 July 2018

Molecular forms of acetyl- and butyrylcholinesterase in human glioma.

artículo científico publicado en 1996

Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease.

artículo científico publicado en 1999

Monomers and dimers of acetylcholinesterase in human meningioma are anchored to the membrane by glycosylphosphatidylinositol.

artículo científico publicado en 1995

Presenilin 1 interacts with acetylcholinesterase and alters its enzymatic activity and glycosylation.

artículo científico publicado en 2008

Presenilin-1 influences processing of the acetylcholinesterase membrane anchor PRiMA.

artículo científico publicado en 2014

Quantification of the transcripts encoding different forms of AChE in various cell types: real-time PCR coupled with standards in revealing the copy number

artículo científico publicado en 2014

Readthrough Acetylcholinesterase Is Increased in Human Liver Cirrhosis ⬇️

artículo científico publicado el 13 de septiembre de 2012

Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update

artículo científico publicado en 2012

Reelin expression and glycosylation patterns are altered in Alzheimer's disease

artículo científico publicado en 2006

Revisiting the role of acetylcholinesterase in Alzheimer’s disease: cross-talk with P-tau and β-amyloid ⬇️

artículo científico publicado el 13 de septiembre de 2011

Ricinus communis agglutinin I reacting and non-reacting butyrylcholinesterase in human cerebrospinal fluid

artículo científico publicado el 28 de septiembre de 1992

Tau phosphorylation by glycogen synthase kinase 3β modulates AChE expression

scientific article published on 21 September 2020

Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study

artículo científico publicado en 2015

Wheat germ agglutinin-binding glycoproteins are decreased in Alzheimer's disease cerebrospinal fluid.

artículo científico publicado en 2001

Lista de obras de Javier Sáez

Acetylcholinesterase activation in organotypic rat hippocampal slice cultures deprived of oxygen and glucose.

Acetylcholinesterase level and molecular isoforms are altered in brain of Reelin Orleans mutant mice ⬇️

Acetylcholinesterase modulates presenilin-1 levels and γ-secretase activity.

Acetylcholinesterase protein level is preserved in the Alzheimer's brain

Alterations in the Balance of Amyloid-β Protein Precursor Species in the Cerebrospinal Fluid of Alzheimer's Disease Patients

Altered expression of brain acetylcholinesterase in FTDP-17 human tau transgenic mice.

Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque deposition.

Altered glycosylation of acetylcholinesterase in Creutzfeldt-Jakob disease.

Altered glycosylation of acetylcholinesterase in the Creutzfeldt-Jakob cerebrospinal fluid

Altered glycosylation of cerebrospinal fluid butyrylcholinesterase in Alzheimer's disease.

Altered levels of acetylcholinesterase in Alzheimer plasma

Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease.

Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer's disease

ApoER2 processing by presenilin-1 modulates reelin expression

Association between acetylcholinesterase and beta-amyloid peptide in Alzheimer's cerebrospinal fluid.

Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease

Biochemical properties of acetyl- and butyrylcholinesterase in human meningioma.

Brain cholinergic impairment in liver failure.

Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis.

C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease

CSF Presenilin-1 complexes are increased in Alzheimer's disease

Caspase-3 activation by beta-amyloid and prion protein peptides is independent from their neurotoxic effect

Cerebrospinal fluid acetylcholinesterase changes after treatment with donepezil in patients with Alzheimer's disease

Changes in acetylcholinesterase expression are associated with altered presenilin-1 levels.

Changes in molecular isoform distribution of acetylcholinesterase in rat cortex and cerebrospinal fluid after intracerebroventricular administration of amyloid beta-peptide.

Characterization of Cerebrospinal Fluid BACE1 Species

Characterization of molecular forms of acetyl- and butyrylcholinesterase in human acoustic neurinomas

Decreased circulating ErbB4 ectodomain fragments as a read-out of impaired signaling function in amyotrophic lateral sclerosis

Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease.

Glycosylation of acetylcholinesterase as diagnostic marker for Alzheimer's disease.

Identification of a 31-bp deletion in the RELN gene causing lissencephaly with cerebellar hypoplasia in sheep.

Inhibition of neurite outgrowth from chick sympathetic neurons by cholinesterase inhibitors is not mediated by binding to cholinesterases

Inhibition of γ-Secretase Leads to an Increase in Presenilin-1.

Intraperitoneal administration of 340 kDa human plasma butyrylcholinesterase increases the level of the enzyme in the cerebrospinal fluid of rats.

Levels of ADAM10 are reduced in Alzheimer's disease CSF

Molecular forms of acetyl- and butyrylcholinesterase in human glioma.

Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease.

Monomers and dimers of acetylcholinesterase in human meningioma are anchored to the membrane by glycosylphosphatidylinositol.

Presenilin 1 interacts with acetylcholinesterase and alters its enzymatic activity and glycosylation.

Presenilin-1 influences processing of the acetylcholinesterase membrane anchor PRiMA.

Quantification of the transcripts encoding different forms of AChE in various cell types: real-time PCR coupled with standards in revealing the copy number

Readthrough Acetylcholinesterase Is Increased in Human Liver Cirrhosis ⬇️

Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update

Reelin expression and glycosylation patterns are altered in Alzheimer's disease

Revisiting the role of acetylcholinesterase in Alzheimer’s disease: cross-talk with P-tau and β-amyloid ⬇️

Ricinus communis agglutinin I reacting and non-reacting butyrylcholinesterase in human cerebrospinal fluid

Tau phosphorylation by glycogen synthase kinase 3β modulates AChE expression

Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study

Wheat germ agglutinin-binding glycoproteins are decreased in Alzheimer's disease cerebrospinal fluid.